Google and Perceptra, a Google technology licensing partner, are joining forces to provide AI-powered diabetic-retinopathy (DR) screening to around 1 million people in underserved communities across ...
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it received regulatory approval to ...
The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...
A new study published in JAMA Ophthalmology reveals that weight loss drugs like Ozempic and similar medications could cause ...
Popular GLP-1 medications like semaglutide and tirzepatide have been linked to rare vision issues, including NAION, raising ...
News Medical on MSN4d
Vision loss risks in patients using popular GLP-1 medications raise concernsA small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...
The following is a summary of “Evaluating lipid-lowering drug targets for full-course diabetic retinopathy,” published in the ...
Can supplementing with vitamins and minerals protect your eye health? Learn more about the role of nutrients in age-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback